Physician profile
Jeremiah Thomas
NPI 1619609021
$1,988.55
in general payments reported to CMS, 2019-2025
10 companies · $1,783 in 2025
The $1,783 reported for 2025 was more than what 81% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $16.57 · 2024: $189 · 2025: $1,783.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,331 · Food and Beverage: $658.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,330.97 |
| Food and Beverage | $657.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $1,649.19 | 2024-2025 | |
| Depuy Synthes Sales INC. | $143.89 | 2025 | Na, Va-Lcp |
| Zimmer Biomet Holdings, INC. | $71.16 | 2024 | Tapestry |
| Cashflow Solutions, LLC | $31.29 | 2025 | Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White |
| Solventum Corporation | $17.24 | 2024 | Kerramax Care, Activ.A.C. |
| Stryker Corporation | $16.57 | 2023 | Variax |
| Acumed LLC | $16.00 | 2025 | Osteomed, Acumed |
| Integra Lifesciences Corporation | $14.67 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Biocomposites INC | $14.56 | 2024 | |
| Paratek Pharmaceuticals, INC. | $13.98 | 2025 | Nuzyra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeremiah Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.